Skip to main content

First Tracks Biotherapeutics, Inc. insider trading

TRAXNASDAQ
$32.99-0.29 (-0.87%)as of Oct 5, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Apr 6, 2026 to Oct 5, 2026. Price (+73.6%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Unlock quarterly net flow

Key players

  • ECEcoR1 Capital, LLC10% Owner8.8845%of company
  • DFDaniel FagaPresident, CEO1.3901%of company
  • PFPaul F. LizzulChief Medical Officer0.1194%of company
  • JPJohn P. SchmidDirector0.1054%of company
  • RJRita JainDirector0.0537%of company
  • JAJohn A. OrwinDirector0.0504%of company
  • BSBenjamin StoneChief Business Officer0.0483%of company
  • MMMagda MarquetDirector0.0447%of company
  • WJWare J. AnthonyDirector0.0438%of company
  • DMDennis M. FentonDirector0.0308%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
TRAXEcoR1 Capital, LLC10% OwnerOpen market sell$65M-307.3%$13.81$65MApr 20, 2026Apr 22, 2026
End of history · 1 transactions
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.